The Medical Advisor

Despite  trillions spent on cancer research  ( The Lancet Oncology ), cancer still  kills around 10 million people a year  ( WHO ) and is a leading cause of death globally, according to the World Health Organization. Cancer research continues to advance at an unprecedented pace, with new treatments offering hope to millions of patients worldwide. The 2026 American Association of Cancer Research (AACR) Annual Meeting took place in San Diego from April 17-22 and reflected how cancer research continues to evolve. Progress is increasingly driven by how advances across biology, technology, and policy come together to shape how we understand disease, develop new treatments, and bring them into practice. A central theme this year was the continued focus on cancer as more than just a collection of tumor cells. It is shaped by a complex ecosystem — immune cells, surrounding tissue, metabolism, and even the microbiome — all interacting in dynamic ways. Credit:  ...

Introduction In an era where conventional cancer treatments often come with significant side effects and variable success rates, alternative therapies are gaining attention for their potential accessibility and lower toxicity. This exploration delves into the emerging use of topical ivermectin—a well-established antiparasitic medication—for treating skin cancers such as basal cell carcinoma, squamous cell carcinoma, and melanoma. Drawing from a compilation of anecdotal success stories, case reports, and preliminary scientific insights, we examine how this affordable, over-the-counter option might disrupt traditional dermatological approaches. While not a substitute for professional medical advice, these narratives highlight patient-driven innovations that challenge the status quo, prompting a closer look at ivermectin's multifaceted mechanisms and real-world applications. Case Presentations Case 16 - 2026: 66 year old Texas nurse with Basal Cell Carcinoma at the nose/cheek jun...